Login / Signup

Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection.

Maria Addolorata BonifacioRiccardo LaterzaAngela VinellaAnnalisa SchirinziMariangela DefilippisFrancesca Di SerioElvira GrandoneAntonio FasanellaMaria Addolorata Mariggiò
Published in: International journal of molecular sciences (2022)
Serological assays are useful in investigating the development of humoral immunity against SARS-CoV-2 in the context of epidemiological studies focusing on the spread of protective immunity. The plaque reduction neutralization test (PRNT) is the gold standard method to assess the titer of protective antibodies in serum samples. However, to provide a result, the PRNT requires several days, skilled operators, and biosafety level 3 laboratories. Therefore, alternative methods are being assessed to establish a relationship between their outcomes and PRNT results. In this work, four different immunoassays (Roche Elecsys ® Anti SARS-CoV-2 S, Snibe MAGLUMI ® SARS-CoV-2 S-RBD IgG, Snibe MAGLUMI ® 2019-nCoV IgG, and EUROIMMUN ® SARS-CoV-2 NeutraLISA assays, respectively) have been performed on individuals healed after SARS-CoV-2 infection. The correlation between each assay and the reference method has been explored through linear regression modeling, as well as through the calculation of Pearson's and Spearman's coefficients. Furthermore, the ability of serological tests to discriminate samples with high titers of neutralizing antibodies (>160) has been assessed by ROC curve analyses, Cohen's Kappa coefficient, and positive predictive agreement. The EUROIMMUN ® NeutraLISA assay displayed the best correlation with PRNT results (Pearson and Spearman coefficients equal to 0.660 and 0.784, respectively), as well as the ROC curve with the highest accuracy, sensitivity, and specificity (0.857, 0.889, and 0.829, respectively).
Keyphrases